Datasheet | September 20, 2022

Self-Collection Safety Liver Panel

Source: Q2 Solutions

Clinical trials are becoming increasingly decentralized, and Q² Solutions is committed to discovering innovative ways of improving the patient and investigator experience.

Today, clinical study participants in the United States can collect a blood specimen for a safety lab test in the comfort of their own home using the Tasso+ SST device, eliminating the need to travel to an investigator site or have a healthcare professional visit their home.

The initial self-collection service is specifically a liver function panel designed to help diagnose and monitor liver disease or damage by measuring the levels of select enzymes, proteins, and compounds in the blood. The panel includes tests for ALT (alanine transaminase), AST (aspartate aminotransferase), ALP (alkaline phosphatase), total bilirubin, direct bilirubin, total protein, and albumin.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader